Q1 2026 Brightspring Health Services Inc Earnings Call Transcript
Key Points
- BrightSpring Health Services Inc (BTSG) reported a 26% year-over-year revenue growth, reaching $3.6 billion in the first quarter of 2026.
- The Pharmacy Solutions segment achieved a 25% year-over-year growth, with revenue reaching $3.2 billion.
- Adjusted EBITDA grew by 45% year-over-year, with a margin improvement of 70 basis points, reaching $190 million.
- The company successfully integrated acquired Amedisys and LHC branches, contributing approximately $30 million in EBITDA.
- BrightSpring's focus on high-quality care resulted in high patient satisfaction scores across various service lines, including a 94% satisfaction score in infusion services.
- Home & Community Pharmacy revenue declined by 9% year-over-year due to a $50 million impact from the IRA and the decision to exit uneconomic customers.
- The company expects a continued revenue impact from the IRA, totaling approximately $175 million for the full year of 2026.
- Despite strong growth, the infusion business is still in the early stages of expanding its chronic specialty portfolio.
- Corporate costs increased, partly due to investments in IT and sales force expansion, impacting overall expenses.
- The company faces ongoing challenges in navigating the competitive landscape with PBMs and potential biosimilar risks.
Hello, and thank you for standing by. Welcome to BrightSpring Health Services, Inc. first quarter 2026 earnings conference call. (Operator Instructions)
I would now like to hand the conference over to David Deuchler. Please go ahead.
Good morning. Thank you for participating in today's conference call. My name is David Deuchler with Investor Relations at BrightSpring. I'm joined on today's call by John Rousseau, Chief Executive Officer; and Jen Phipps, Chief Financial Officer. Earlier today, BrightSpring released financial results for the quarter ended March 31, 2026.
A copy of the press release and presentation is available on the company's Investor Relations website. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions.
Such forward-looking statements are not guarantees of future
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
